Supplementary Data from Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

Authors :: Tae-You Kim
Yung-Jue Bang
Seock-Ah Im
Do Youn Oh
Hyung-Seok Hur
Sae-Won Han
Hwang-Phill Kim
Young-Kwang Yoon
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Data from Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

Full Text Access

Tools